Infusio Glucosi

Glucose, the active ingredient in Infusio Glucosi, is a carbohydrate (glucose) solution presented as an intravenous solution for intravenous use. It is employed to raise blood glucose levels and provide fluid and electrolyte support in patients experiencing hypoglycemia, requiring fluid replacement, or receiving parenteral nutrition. GNH USA supplies Infusio Glucosi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide. The company adheres to EU GMP standards and provides reliable logistics for clinical and acute care settings. Products are shipped with full documentation to meet regulatory requirements.

Infusio Glucosi is used in clinical settings to address carbohydrate deficits and fluid‑electrolyte needs across several medical conditions.

- Hypoglycemia: provides rapid elevation of blood glucose, helping to prevent neuroglycopenic symptoms such as confusion, seizures, and loss of consciousness. - Fluid replacement: restores intravascular volume, supplies water and electrolytes, and supports hemodynamic stability in patients with dehydration or blood loss. - Parenteral nutrition: delivers a sterile carbohydrate source that contributes essential calories, enabling energy provision when oral intake is not possible. - Peri‑operative glucose management: maintains stable blood glucose concentrations during surgery, reducing the risk of intra‑operative hypoglycemia and supporting postoperative recovery.

Infusio Glucosi may be associated with adverse reactions typical of intravenous carbohydrate solutions.

Common Side Effects: - Hyperglycemia: transient elevation of blood glucose that may cause mild symptoms. - Local irritation: redness or discomfort at the infusion site. - Phlebitis: inflammation of the vein used for administration. - Nausea or headache: mild systemic reactions reported in some patients. - Hypokalemia: low potassium levels due to shifts with glucose infusion. - Transient hypotension: slight drop in blood pressure during rapid infusion.

Serious or Rare Side Effects: - Severe hyperglycemia: marked rise in glucose requiring medical intervention. - Anaphylactic reaction: rare allergic response with rash, breathing difficulty, or hypotension. - Volume overload: excessive fluid administration leading to pulmonary edema.

When using Infusio Glucosi, clinicians should observe several precautionary measures to ensure patient safety and product integrity.

- Indication verification: confirm hypoglycemia or fluid need before administration. - Blood glucose monitoring: check levels before, during, and after infusion. - Infusion rate control: administer at recommended rate to avoid rapid glucose spikes. - Electrolyte assessment: evaluate serum electrolytes to prevent imbalances. - Compatibility check: ensure solution is compatible with other IV fluids or medications. - Store at ambient temperature: keep in original container, protect from light and moisture.

Infusio Glucosi can interact with other agents administered intravenously or affecting glucose metabolism.

Major Interactions (Avoid): - Insulin therapy: concurrent high‑dose insulin may cause severe hypoglycemia if glucose infusion is insufficient. - Sodium‑containing solutions: mixing with high‑sodium fluids can lead to electrolyte overload and hypernatremia.

Moderate Interactions (Monitor Closely): - Sulfonylureas or meglitinides: oral hypoglycemic agents may augment glucose‑lowering effect, requiring glucose monitoring. - Loop diuretics: increased urinary loss of electrolytes may necessitate electrolyte replacement when large volumes of glucose solution are given. - Beta‑blockers: may mask symptoms of hypoglycemia, so careful glucose level observation is advised. - Calcium channel blockers: may affect vascular tone, monitor for hypotension during rapid infusion.